Koskinen P - Search Results

1

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Frick MH, et al. Among authors: koskinen p. N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001. N Engl J Med. 1987. PMID: 3313041 Clinical Trial.

2

The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.

Huttunen JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L, Mänttäri M, Frick MH. Huttunen JK, et al. Among authors: koskinen p. J Intern Med. 1994 Jan;235(1):31-9. doi: 10.1111/j.1365-2796.1994.tb01029.x. J Intern Med. 1994. PMID: 8283157 Clinical Trial.

3

The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up.

Heinonen OP, Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Tenkanen L, Frick MH. Heinonen OP, et al. Among authors: koskinen p. J Intern Med. 1994 Jan;235(1):41-9. doi: 10.1111/j.1365-2796.1994.tb01030.x. J Intern Med. 1994. PMID: 8283158 Clinical Trial.

4

Seasonal variation in high density lipoprotein cholesterol.

Mänttäri M, Javela K, Koskinen P, Pikkarainen J, Manninen V, Huttunen JK, Frick MH. Mänttäri M, et al. Among authors: koskinen p. Atherosclerosis. 1993 May;100(2):257-65. doi: 10.1016/0021-9150(93)90212-d. Atherosclerosis. 1993. PMID: 8357358

5

Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.

Frick MH, Heinonen OP, Huttunen JK, Koskinen P, Mänttäri M, Manninen V. Frick MH, et al. Among authors: koskinen p. Ann Med. 1993 Feb;25(1):41-5. doi: 10.3109/07853899309147855. Ann Med. 1993. PMID: 8435186 Clinical Trial.

6

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.

Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. Koskinen P, et al. Diabetes Care. 1992 Jul;15(7):820-5. doi: 10.2337/diacare.15.7.820. Diabetes Care. 1992. PMID: 1516498 Clinical Trial.

7

Leukocytes as a coronary risk factor in a dyslipidemic male population.

Mänttäri M, Manninen V, Koskinen P, Huttunen JK, Oksanen E, Tenkanen L, Heinonen OP, Frick MH. Mänttäri M, et al. Among authors: koskinen p. Am Heart J. 1992 Apr;123(4 Pt 1):873-7. doi: 10.1016/0002-8703(92)90690-w. Am Heart J. 1992. PMID: 1549995

8

DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment.

Aalto-Setälä K, Kontula K, Mänttäri M, Huttunen J, Manninen V, Koskinen P, Frick HM. Aalto-Setälä K, et al. Among authors: koskinen p. Clin Pharmacol Ther. 1991 Aug;50(2):208-14. doi: 10.1038/clpt.1991.126. Clin Pharmacol Ther. 1991. PMID: 1678324

9

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Manninen V, et al. Among authors: koskinen p. Circulation. 1992 Jan;85(1):37-45. doi: 10.1161/01.cir.85.1.37. Circulation. 1992. PMID: 1728471

10

Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.

Koskinen P, Kovanen PT, Tuomilehto J, Manninen V. Koskinen P, et al. Arch Intern Med. 1992 Jan;152(1):90-6. Arch Intern Med. 1992. PMID: 1728934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page